If rectal cancer is detected in its early stages, such as stage I or II, curative surgery can be performed. Postoperative decisions regarding the necessity of adjuvant radiotherapy or chemotherapy are based on the postoperative pathological staging. Early-stage rectal cancer patients can achieve a cure through surgical treatment combined with some postoperative adjuvant therapies. After curative surgery, the overall five-year survival rate is approximately 50%. However, this rate can vary and is associated with several factors such as postoperative pathology, whether there is lymph node metastasis, the presence of vascular tumor thrombi, and nerve invasion, among other high-risk factors for recurrence, showing certain individual differences. Yet, early-stage rectal cancer patients can achieve a cure through these methods.